Skip to main content
What types of page to search?

Popular pages: Undergraduate Postgraduate PhD Accommodation Research International students

Alternatively use our A-Z index.

About CAMCON26

The 3rd International CAM Conference will take place in Liverpool, United Kingdom, from 30 June to 2 July 2026, bringing together experts in chorioallantoic membrane (CAM) models from around the world. 

Conference aims

There has been an amazing resurgence in use of avian chorioallantoic membrane (CAM) models in recent years. Emerging experimental pipelines consolidate their use as a versatile and ethically sound platform for complex disease modelling, highlighting their ability to support molecular-level and three-dimensional investigation of tissue regeneration, tumour biology, and therapeutic response.

The primary aims of the conference are to:

  • Showcase CAM models as powerful tools in molecular and translational biology, capable of bridging from in vitro to in vivo systems, whilst reducing reliance on traditional and less sustainable animal models
  • Highlight cutting-edge developments in CAM models to study cancer, non oncological disease, regenerative medicine and biomaterials, underscoring how they enable real-time in vivo analysis of gene expression, signalling pathways, and cellular interactions
  • Explore recent development of complex CAM-based models using patient-derived tissue in preclinical research to evaluate precision and molecular therapies, integrating the model with emerging imaging and spatial ‘omics technologies
  • Discuss the enablers and barriers to uptake of CAM models in academia and pharma, including regulatory challenges and standardisation, reflecting our goal of enabling broader adoption
  • Foster the development of trainees and junior scientists, and collaborations across biomedical disciplines to accelerate translational research.

Themes

The conference will be opened by one of the leading researchers who re-invigorated the CAM field, Professor Domenico Ribatti, focusing on new applications in lymphangiogenesis, followed by a keynote talk from Dr Megan Davey on her work generating genetically-modified egg models that bring exciting new possibilities in understanding cellular interactions on the CAM.

The six main conference themes focus on:

  • Non-oncological models
  • Regenerative medicine and biomaterials
  • Modelling the hallmarks of cancer
  • Complex cancer models
  • Pre-clinical applications
  • Biomolecular imaging.

Workshops will also discuss key issues: enabling uptake of CAM research; the 3Rs, and sustainability in research; and barriers to uptake of CAM models, with a focus on Pharma.

Target audience

The conference will attract scientists with a breadth of backgrounds in animal models, physiological systems, immunology, cell biology, biochemistry, molecular biology, gene expression, cell signalling, metabolism, molecular medicine, tissue engineering, bioimaging, ‘omics analysis, developmental, regenerative and cancer biology.

It is relevant to academic researchers and technical professionals across all career stages, from postgraduate students to senior professors; as well as delegates from the pharmaceutical and other industries, research funders, publishers, and organisations promoting 3Rs approaches.

Organising committee

Scientific committee